Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by businessprofon Jun 06, 2018 3:48pm
81 Views
Post# 28134703

Part of TWO ETFs Indicies, not just one!

Part of TWO ETFs Indicies, not just one!

I was just reviewing the latest updates on the website, which took me back to some old news.  As always, and just as a lot of us have been commenting, compared to 95% of these 'late stage applicants' that have nothing more than a 'plan' to grow pot in a building that’s not even there yet, LIB has so much going for it!  Plants have already been growing at the Just Kush property - for years, under an older smaller scale license.  Sometimes I forget about these things.  LIB is expanding this output for the new license, but the location is established and plants have been grown there!  Existing growing provides an ideal launch pad to step into the new larger scale licensing.  If you look at a lot of the smaller licensees on the ACMPR page today, most of them were previous growers under the older licenses – like Just Kush.  I’m looking at these other ‘late stage applicant’ stocks in the .20s and .30s and none of them have started with an existing grow operation.  This puts LIB out front for sure.  Then, there’s North Road, the pet CBD testing, and a variety of other relationships that LIB is leveraging.  It's not just a great story - it's a unique and differentiated model for profit, which is likely why LIB is part of TWO ETF indicies, not just one!  So, rehashing some old news that I had forgotten about...

We know LIB is part of the Horizons Jr ETF, which speaks volumes to the market’s faith in this stock.  However, upon reviewing some of LIB’s news today, I noticed something about which I had completely forgotten – it is also part of the Solactive German ETF for emerging MJ companies, and those Germans are scrupulous:
https://www.libleaf.ca/news-releases/2018/01/30/inclusion-new-solactive-emerging-marijuana-growers-index/
Yes, old news, but news I think we need to re-visit.  Just like Horizons, Solactive wouldn’t touch a holding without some serious vetting and research.  Guys, that’s 2 serious ETFs that have chosen LIB as a holding.  Funny, I don’t see CANN as being part of either ETF, and they are consistently worth more than LIB.  Granted, CANN is going to have huge output, and I do like that stock, but when institutional investment firms choose LIB, we need to see this for what is – legitimate faith in the future of this company from firms who do their due diligence like it’s their freaking job…oh wait, it is their job!  Anyway, I’m sure you get the point.  The manipulators took this thing to the bottom and these ETFs never dropped a share.  The bashers can blah blah blah all day long, but it still doesn't change the fact that TWO serious ETFs have decided that LIB is a worthy investment. 

There is so much good news here that in the absence of ‘news releases’, I think we just need to remind ourselves why we got into LIB in the first place.  If all of us would stop giving into these ridiculous bids from the manipulators and also stop trading on freaking pennies, we’d be back in the 40s in days – no small cap has a story like LIB!
 
 

<< Previous
Bullboard Posts
Next >>